Home > Products > BAFF & B7RP1 > Recombinant Anti-BAFF x Anti-B7RP1 Bispecific Antibody (Tandem Diabody)

Recombinant Anti-BAFF x Anti-B7RP1 Bispecific Antibody (Tandem Diabody)  (CAT#: T-BSDB-018)

Recombinant Anti-BAFF x Anti-B7RP1 Bispecific Antibody (Tandem Diabody) is designed to be expressed as a monomeric subunit (single chain Diabody, scDb), with four variable domains from two parental antibodies. Then the two peptide chains can dimerize in a head-to-tail fashion. This BsAb can bind and inactivate two ligands simultaneously. It can inhibit B cell survival and T cell costimulation. It is designed for the research of Systemic lupus erythematosus (SLE) therapy.
Datasheet INQUIRY

Specifications

Targets
BAFF & B7RP1
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Systemic lupus erythematosus (SLE)

Targets

Target 1
BAFF
Gene ID
UniProt ID
Alternative Names
TNFSF13B; TNF superfamily member 13b; DTL; B cell activating factor; BAFF; BLYS; CD257; TALL1; THANK; ZTNF4; TALL-1; TNFSF20
Target 2
B7RP1
Gene ID
UniProt ID
Alternative Names
ICOSLG; inducible T cell costimulator ligand; B7H2; GL50; B7-H2; B7­related protein; B7RP1; CD275; ICOSL; LICOS; B7RP-1; ICOS-L
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "BAFF & B7RP1"
See other bsAb targets related to "BAFF"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-BAFF x Anti-B7RP1 Bispecific Antibody (Tandem Diabody) (T-BSDB-018). Click the button below to contact us or submit your feedback about this product.